Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring... see more

Recent & Breaking News (CSE:BUX)

BioMark's Market Update Report

TheNewsWire February 4, 2020

BioMark's Scientific Advisor Named Dean of Schulich School of Medicine and Dentistry

TheNewsWire January 21, 2020

BioMark Announces Appointment of Scientific and Medical Advisors, Grant of Stock Options and Changes in Board of Directors

TheNewsWire December 31, 2019

BioMark Diagnostics Reviews 2019 and Outlines Plans for 2020

TheNewsWire December 19, 2019

BioMark Closes the Over-Subscribed Private Placement Offering

TheNewsWire December 16, 2019

Canadian Trade Commissioner Service Features BioMark Diagnostics Next Generation Cancer Diagnostics

TheNewsWire December 11, 2019

Correction: BioMark Announces Private Placement

TheNewsWire November 21, 2019

BioMark Announces Private Placement

TheNewsWire November 21, 2019

BioMark Signs Letter of Intent for Licensing Relationship for Clinical Validation and Development

TheNewsWire November 19, 2019

New Scientific Publication Further Supports BioMark's Assay

TheNewsWire August 27, 2019

BioMark's Liquid Biopsy Scientific Paper to Be Featured as Cover on Cancers Upcoming Issue

TheNewsWire August 19, 2019

New Advances in Liquid Biopsy to Increase BioMark's Assay Performance

TheNewsWire August 13, 2019

The University of Maryland School of Medicine Enters Research Collaboration with BioMark Diagnostics

TheNewsWire June 26, 2019

BioMark announces Debt Settlement

TheNewsWire June 18, 2019

BioMark Announces New Patent Granted in United States

TheNewsWire May 30, 2019

Revision on Total Funding Secured by BioMark and its Team of Collaborators on CHRP Application

TheNewsWire May 1, 2019

BioMark and its Team of Collaborators Secure CHRP Funding

TheNewsWire April 17, 2019

BioMark Closes the Private Placement Offering

TheNewsWire April 16, 2019

BioMark Announces Private Placement

TheNewsWire April 9, 2019

BioMark's Abstract Accepted for 2019 ASCO Online Publication

TheNewsWire April 3, 2019